Indobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Apixaban | The risk or severity of adverse effects can be increased when Indobufen is combined with Apixaban. |
| Dasatinib | Dasatinib may increase the anticoagulant activities of Indobufen. |
| Ursodeoxycholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Ursodeoxycholic acid. |
| Glycochenodeoxycholic Acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Glycochenodeoxycholic Acid. |
| Cholic Acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Cholic Acid. |
| Glycocholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Glycocholic acid. |
| Deoxycholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Deoxycholic acid. |
| Taurocholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Taurocholic acid. |
| Obeticholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Obeticholic acid. |
| Chenodeoxycholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Chenodeoxycholic acid. |
| Taurochenodeoxycholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Taurochenodeoxycholic acid. |
| Tauroursodeoxycholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Tauroursodeoxycholic acid. |
| Bamet-UD2 | The risk or severity of adverse effects can be increased when Indobufen is combined with Bamet-UD2. |
| Dehydrocholic acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Dehydrocholic acid. |
| Hyodeoxycholic Acid | The risk or severity of adverse effects can be increased when Indobufen is combined with Hyodeoxycholic Acid. |
| Glucosamine | Glucosamine may increase the antiplatelet activities of Indobufen. |
| Ibritumomab tiuxetan | The risk or severity of adverse effects can be increased when Indobufen is combined with Ibritumomab tiuxetan. |
| Ibrutinib | The risk or severity of adverse effects can be increased when Ibrutinib is combined with Indobufen. |
| Obinutuzumab | The risk or severity of adverse effects can be increased when Indobufen is combined with Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the antiplatelet activities of Indobufen. |
| Rivaroxaban | Indobufen may increase the anticoagulant activities of Rivaroxaban. |
| Tipranavir | Tipranavir may increase the antiplatelet activities of Indobufen. |
| Urokinase | Indobufen may increase the anticoagulant activities of Urokinase. |
| Vitamin E | Vitamin E may increase the antiplatelet activities of Indobufen. |
| Amlodipine | Indobufen may decrease the antihypertensive activities of Amlodipine. |
| Phentermine | The risk or severity of hypertension can be increased when Phentermine is combined with Indobufen. |
| Midodrine | The risk or severity of hypertension can be increased when Midodrine is combined with Indobufen. |
| Eletriptan | The risk or severity of hypertension can be increased when Eletriptan is combined with Indobufen. |
| Isoetharine | The risk or severity of hypertension can be increased when Isoetharine is combined with Indobufen. |
| Ziprasidone | The risk or severity of hypertension can be increased when Ziprasidone is combined with Indobufen. |
| Methysergide | The risk or severity of hypertension can be increased when Methysergide is combined with Indobufen. |
| Cabergoline | The risk or severity of hypertension can be increased when Cabergoline is combined with Indobufen. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indobufen. |
| Dihydroergotamine | The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Indobufen. |
| Methylergometrine | The risk or severity of hypertension can be increased when Methylergometrine is combined with Indobufen. |
| Norepinephrine | The risk or severity of hypertension can be increased when Norepinephrine is combined with Indobufen. |
| Mirtazapine | The risk or severity of hypertension can be increased when Mirtazapine is combined with Indobufen. |
| Phenylephrine | The risk or severity of hypertension can be increased when Phenylephrine is combined with Indobufen. |
| Phenylpropanolamine | The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Indobufen. |
| Promazine | The risk or severity of hypertension can be increased when Promazine is combined with Indobufen. |
| Droperidol | The risk or severity of hypertension can be increased when Droperidol is combined with Indobufen. |
| Doxapram | The risk or severity of hypertension can be increased when Doxapram is combined with Indobufen. |
| Atropine | The risk or severity of hypertension can be increased when Atropine is combined with Indobufen. |
| Lisuride | The risk or severity of hypertension can be increased when Lisuride is combined with Indobufen. |
| Metaraminol | The risk or severity of hypertension can be increased when Metaraminol is combined with Indobufen. |
| Epinephrine | The risk or severity of hypertension can be increased when Epinephrine is combined with Indobufen. |
| Thioridazine | The risk or severity of hypertension can be increased when Thioridazine is combined with Indobufen. |
| Ergotamine | The risk or severity of hypertension can be increased when Ergotamine is combined with Indobufen. |
| Nicergoline | The risk or severity of hypertension can be increased when Nicergoline is combined with Indobufen. |
| Sufentanil | The risk or severity of hypertension can be increased when Sufentanil is combined with Indobufen. |
| Methoxamine | The risk or severity of hypertension can be increased when Methoxamine is combined with Indobufen. |
| Risperidone | The risk or severity of hypertension can be increased when Risperidone is combined with Indobufen. |
| Isoflurane | The risk or severity of hypertension can be increased when Isoflurane is combined with Indobufen. |
| Propiomazine | The risk or severity of hypertension can be increased when Propiomazine is combined with Indobufen. |
| Alfentanil | The risk or severity of hypertension can be increased when Alfentanil is combined with Indobufen. |
| Orciprenaline | The risk or severity of hypertension can be increased when Orciprenaline is combined with Indobufen. |
| Propofol | The risk or severity of hypertension can be increased when Propofol is combined with Indobufen. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Indobufen. |
| Trifluoperazine | The risk or severity of hypertension can be increased when Trifluoperazine is combined with Indobufen. |
| Pseudoephedrine | The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Indobufen. |
| Benzphetamine | The risk or severity of hypertension can be increased when Benzphetamine is combined with Indobufen. |
| Ritodrine | The risk or severity of hypertension can be increased when Ritodrine is combined with Indobufen. |
| Flupentixol | The risk or severity of hypertension can be increased when Flupentixol is combined with Indobufen. |
| Remifentanil | The risk or severity of hypertension can be increased when Remifentanil is combined with Indobufen. |
| Bitolterol | The risk or severity of hypertension can be increased when Bitolterol is combined with Indobufen. |
| Oxymetazoline | The risk or severity of hypertension can be increased when Oxymetazoline is combined with Indobufen. |
| Diethylpropion | The risk or severity of hypertension can be increased when Diethylpropion is combined with Indobufen. |
| Salmeterol | The risk or severity of hypertension can be increased when Salmeterol is combined with Indobufen. |
| Naratriptan | The risk or severity of hypertension can be increased when Naratriptan is combined with Indobufen. |
| Formoterol | The risk or severity of hypertension can be increased when Formoterol is combined with Indobufen. |
| Frovatriptan | The risk or severity of hypertension can be increased when Frovatriptan is combined with Indobufen. |
| Methoxyflurane | The risk or severity of hypertension can be increased when Methoxyflurane is combined with Indobufen. |
| Ergoloid mesylate | The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Indobufen. |
| Isoprenaline | The risk or severity of hypertension can be increased when Isoprenaline is combined with Indobufen. |
| Arbutamine | The risk or severity of hypertension can be increased when Arbutamine is combined with Indobufen. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Indobufen. |
| Halothane | The risk or severity of hypertension can be increased when Halothane is combined with Indobufen. |
| Pergolide | The risk or severity of hypertension can be increased when Pergolide is combined with Indobufen. |
| Desflurane | The risk or severity of hypertension can be increased when Desflurane is combined with Indobufen. |
| Bromocriptine | The risk or severity of hypertension can be increased when Bromocriptine is combined with Indobufen. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Indobufen. |
| Aripiprazole | The risk or severity of hypertension can be increased when Aripiprazole is combined with Indobufen. |
| Ergometrine | The risk or severity of hypertension can be increased when Ergometrine is combined with Indobufen. |
| Lisdexamfetamine | The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Indobufen. |
| Fenoterol | The risk or severity of hypertension can be increased when Fenoterol is combined with Indobufen. |
| Pirbuterol | The risk or severity of hypertension can be increased when Pirbuterol is combined with Indobufen. |
| Ephedra sinica root | The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Indobufen. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Indobufen. |
| Mephentermine | The risk or severity of hypertension can be increased when Mephentermine is combined with Indobufen. |
| Procaterol | The risk or severity of hypertension can be increased when Procaterol is combined with Indobufen. |
| Yohimbine | The risk or severity of hypertension can be increased when Yohimbine is combined with Indobufen. |
| Methotrimeprazine | The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Indobufen. |
| Clenbuterol | The risk or severity of hypertension can be increased when Clenbuterol is combined with Indobufen. |
| Bambuterol | The risk or severity of hypertension can be increased when Bambuterol is combined with Indobufen. |
| MMDA | The risk or severity of hypertension can be increased when MMDA is combined with Indobufen. |
| Midomafetamine | The risk or severity of hypertension can be increased when Midomafetamine is combined with Indobufen. |
| 2,5-Dimethoxy-4-ethylamphetamine | The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Indobufen. |
| 4-Methoxyamphetamine | The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Indobufen. |
| 4-Bromo-2,5-dimethoxyamphetamine | The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Indobufen. |
| Tenamfetamine | The risk or severity of hypertension can be increased when Tenamfetamine is combined with Indobufen. |